Follow PharmaTimes: News RSS, filter it, and define how you want to receive the news (via Email, RSS, Telegram, WhatsApp etc.) https://follow.it/pharmatimes-news-rss Sun, 26 Jun 2022 01:49:32 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqTnxkkiXI_rIIAmcWJ0TmB COVID-19 Beta-containing vaccine provides 75.1% efficacy in participants previously infected with coronavirus]]> Fri, 24 Jun 2022 12:56:14 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqTnxkkiXI_rIIAmcWJ0TmB https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrXMP0tpLe_DKbel3Iu4GjH MHRA extends UCB’s therapy for the treatment of partial-onset seizures]]> Fri, 24 Jun 2022 12:53:10 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrXMP0tpLe_DKbel3Iu4GjH https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoNzXB6owSFk-9WSSr4-0sP Global surveillance systems show that recorded cases do not include any deaths]]> Thu, 23 Jun 2022 13:39:25 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoNzXB6owSFk-9WSSr4-0sP https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoNzXB6owSFk0ZPHFZJLI3I The company has renewed its pledge to eliminate neglected tropical diseases and malaria over five years]]> Thu, 23 Jun 2022 13:38:14 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoNzXB6owSFk0ZPHFZJLI3I https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoGBPJ_hvx7UrDXWBZfdr71 Novartis receives approval from the European Commission for Tabrecta for the treatment of non-small cell lung cancer]]> Wed, 22 Jun 2022 14:28:38 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoGBPJ_hvx7UrDXWBZfdr71 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoGBPJ_hvx7UntuT6pSmY81 The MS Society responds as MS therapy Fampyra is rejected]]> Wed, 22 Jun 2022 14:23:49 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoGBPJ_hvx7UntuT6pSmY81 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMojqoRqpwwEZuGkz6RCC25z Eplontersen significantly improved patient-reported quality of life following successful research]]> Tue, 21 Jun 2022 13:44:10 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMojqoRqpwwEZuGkz6RCC25z https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo_Q8gfMMCt1GsGk81fO-bN Pre-clinical screening technology could increase cancer test numbers by 50 times]]> Tue, 21 Jun 2022 13:40:38 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMo_Q8gfMMCt1GsGk81fO-bN https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoaBwvEJj1g4AC0qH-r7xlT The joint aim of the companies was to provide vaccines to vulnerable communities]]> Mon, 20 Jun 2022 14:27:03 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMoaBwvEJj1g4AC0qH-r7xlT https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqdLMAhpThvn1e5jCclomp- The discovery may lead to development of drugs that halt disease progression and stop memory loss]]> Mon, 20 Jun 2022 13:38:28 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqdLMAhpThvn1e5jCclomp- https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrmLZGN8hpmZIvmyuk5fxzE Therapy represents the first STAMP inhibitor for patients with chronic myeloid leukaemia]]> Fri, 17 Jun 2022 13:02:15 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrmLZGN8hpmZIvmyuk5fxzE https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrmLZGN8hpmZASngkwrdsok Verzenios in combination with endocrine treats people with early breast cancer who are at high-risk of recurrence]]> Fri, 17 Jun 2022 12:58:33 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrmLZGN8hpmZASngkwrdsok https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqqeh-9tRk9-lRpWVnEcNkS The MT-RNR1 test was assessed under NICE’s diagnostics assessment programme]]> Thu, 16 Jun 2022 13:52:34 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqqeh-9tRk9-lRpWVnEcNkS https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrZ1VZXstQngAVLTsI7B9NX The companies will focus on the development of biomarkers for chronic diseases]]> Thu, 16 Jun 2022 13:47:23 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrZ1VZXstQngAVLTsI7B9NX https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMplQa306OZOg3tuT6pSmY81 The deal will boost CatSci’s ability to deliver best-in-class medicines to patients worldwide]]> Wed, 15 Jun 2022 14:26:33 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMplQa306OZOg3tuT6pSmY81 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMplQa306OZOg5JTpfXVttXD Jazz Pharmaceuticals and Redx announce that pan-RAF inhibitor will enter clinical development]]> Wed, 15 Jun 2022 14:23:14 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMplQa306OZOg5JTpfXVttXD https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqLASUG9qzi3oIAmcWJ0TmB The three-year project will focus on molecular representations and computational tools]]> Tue, 14 Jun 2022 13:46:34 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMqLASUG9qzi3oIAmcWJ0TmB https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrnCcR0D_n2xX-fx8LWuXng Funding will enable the development of Spirea’s pipeline of antibody drug conjugate therapeutics for the treatment of solid tumours]]> Tue, 14 Jun 2022 13:41:06 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMrnCcR0D_n2xX-fx8LWuXng https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMp_MavXxsq-DEQqW5gBv7mX It is the first treatment in its class to receive NICE approval for cardiovascular risk reduction]]> Mon, 13 Jun 2022 12:47:48 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMp_MavXxsq-DEQqW5gBv7mX https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMp_MavXxsq-DOm6srrLMsqK First-in-human clinical trial in patients with triple negative breast cancer, ovarian cancer, head and neck cancer and renal cancer]]> Mon, 13 Jun 2022 12:44:24 +0200 https://api.follow.it/track-rss-story-click/v3/c-g1Pb4wqMp_MavXxsq-DOm6srrLMsqK